Zentalis Pharmaceuticals, Inc. (ZNTL)
2.96
-0.20
(-6.33%)
USD |
NASDAQ |
Jan 16, 16:00
2.91
-0.05
(-1.69%)
After-Hours: 20:00
Zentalis Pharmaceuticals EPS Diluted (Quarterly): -0.37 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| STAAR Surgical Co. | 0.1758 |
| Glaukos Corp. | -0.2828 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.69M |
| Total Expenses (Quarterly) | 26.69M |
| Enterprise Value | -26.38M |
| Earnings Yield | -70.38% |
| Normalized Earnings Yield | -66.19 |